XML 107 R93.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK INCENTIVE PLANS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 28, 2020
Dec. 29, 2017
Jun. 30, 2021
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Compensation expense to restricted shares $ 22,200   $ 100,000 $ 100,000 $ 400,000 $ 300,000
Fair value of options granted         150,000.0 220,000.0
Compensation expense       $ 100,000 $ 2,000,000.0 2,000,000.0
Unrecognized compensation expense     $ 0     $ 100,000
Common stock issued     30,000   68,201,900 59,476,268
Exercise price         $ 0.74  
Unrecognized fair value of compensation cost         $ 79,000 $ 79,000
Weighted Average Remaining Contractual Life (years)         10 months 6 days 7 months 20 days
Term of exercise period         10 years  
Equity Incentive Plan [Member]            
Common stock available for grant 5,000,000 5,000,000        
Equity incentive plan, description   The Plan will continue in effect until its termination by the Committee; provided, however, that all Awards must be granted, if at all, within ten (10) years from the Effective Date.        
Stock Options [Member]            
Unrecognized fair value of compensation cost     $ 3,000,000      
Aggregate Intrinsic Value, Outstanding     $ 2,100,000   $ 0  
Consultant [Member]            
Restricted common stock issued         150,000  
Stock options issued, shares         1,518,194 90,000
Restricted Stock Units [Member]            
Compensation expense         $ 500,000 $ 500,000
Restricted common stock issued     431,578   629,338  
Unrecognized fair value of compensation cost     $ 400,000     600,000
Restricted Common Stock [Member]            
Restricted common stock issued         338,443  
Unrecognized fair value of compensation cost         $ 600,000 $ 300,000
Weighted Average Remaining Contractual Life (years)         0 years  
Nonstatutory Stock Options [Member]            
Restricted common stock issued         150,000  
Common stock, shares issued during the period, shares         3,510,364 1,555,526
Awarded vesting period         4 years